Tianjin Ringpu Bio Tech (300119) — Financial Flexibility Index
Tianjin Ringpu Bio Tech (300119) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of CN¥128.27 Million (operating CF CN¥105.02 Million minus capex CN¥23.24 Million) represents 0% of total liabilities (CN¥2.54 Billion). Check Tianjin Ringpu Bio Tech (300119) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tianjin Ringpu Bio Tech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Tianjin Ringpu Bio Tech across 19 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tianjin Ringpu Bio Tech.
Annual Financial Flexibility Index for Tianjin Ringpu Bio Tech (2007–2025)
Year-by-year free cash flow to debt coverage for Tianjin Ringpu Bio Tech. Explore Tianjin Ringpu Bio Tech (300119) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥473.64 Million | CN¥297.53 Million | CN¥2.47 Billion | ▼ -38.4% |
| 2024 | 0.31x | CN¥920.88 Million | CN¥735.55 Million | CN¥2.96 Billion | ▼ -10.5% |
| 2023 | 0.35x | CN¥622.68 Million | CN¥378.20 Million | CN¥1.79 Billion | ▼ -26.8% |
| 2022 | 0.47x | CN¥761.92 Million | CN¥389.49 Million | CN¥1.61 Billion | ▼ -5.7% |
| 2021 | 0.50x | CN¥688.50 Million | CN¥382.63 Million | CN¥1.37 Billion | ▼ -9.6% |
| 2020 | 0.56x | CN¥647.61 Million | CN¥388.44 Million | CN¥1.16 Billion | ▲ +9.6% |
| 2019 | 0.51x | CN¥613.31 Million | CN¥383.61 Million | CN¥1.21 Billion | ▲ +31.7% |
| 2018 | 0.39x | CN¥287.33 Million | CN¥174.88 Million | CN¥744.03 Million | ▲ +33.5% |
| 2017 | 0.29x | CN¥216.44 Million | CN¥107.57 Million | CN¥747.95 Million | ▼ -45.9% |
| 2016 | 0.53x | CN¥335.80 Million | CN¥207.67 Million | CN¥627.74 Million | ▼ -17.6% |
| 2015 | 0.65x | CN¥376.36 Million | CN¥225.27 Million | CN¥579.77 Million | ▼ -46.4% |
| 2014 | 1.21x | CN¥311.48 Million | CN¥128.37 Million | CN¥257.23 Million | ▲ +0.7% |
| 2013 | 1.20x | CN¥340.29 Million | CN¥88.68 Million | CN¥282.89 Million | ▼ -3.2% |
| 2012 | 1.24x | CN¥257.29 Million | CN¥89.92 Million | CN¥206.99 Million | ▼ -20.9% |
| 2011 | 1.57x | CN¥275.10 Million | CN¥90.29 Million | CN¥175.12 Million | ▲ +91.4% |
| 2010 | 0.82x | CN¥160.61 Million | CN¥112.82 Million | CN¥195.66 Million | ▲ +39.2% |
| 2009 | 0.59x | CN¥95.93 Million | CN¥64.59 Million | CN¥162.63 Million | ▼ -42.7% |
| 2008 | 1.03x | CN¥87.73 Million | CN¥68.07 Million | CN¥85.18 Million | ▲ +43.2% |
| 2007 | 0.72x | CN¥36.14 Million | CN¥19.15 Million | CN¥50.26 Million | — |